Now showing items 1-10 of 68
Perceptions about mental healthcare for people with epilepsy in Africa.
BACKGROUND: Mental illness is commonly comorbid with epilepsy. In sub-Saharan Africa there exists limited access to neurological and psychiatric services predisposing to a "treatment gap" in epilepsy and mental healthcare. ...
Impact of COVID-19 on mental health research: is this the breaking point?
There are many structural problems facing the UK at present, from a weakened National Health Service to deeply ingrained inequality. These challenges extend through society to clinical practice and have an impact on current ...
Keep safe: The when, why and how of epilepsy risk communication
Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study.
BACKGROUND: A quarter of people with Intellectual Disability (ID) in the UK have epilepsy compared to 0.6% in the general population and die much younger. Epilepsy is associated with two-fifths of all deaths with related ...
Lacosamide in the general population and in people with intellectual disability: Similar responses?
PURPOSE: Epilepsy prevalence is significantly higher in people with Intellectual Disability (ID) compared to people with epilepsy (PWE) from the general population. Increased psychological and behavioural problems, healthcare ...
Valproate risk form-Surveying 215 clinicians involving 4775 encounters.
OBJECTIVES: Annual completion of a Valproate Risk Acknowledgement Form (RAF) is mandated in the United Kingdom due to neurodevelopmental risks of in utero valproate exposure. The number of women of childbearing potential ...
Valproate prescribing practices for women with intellectual disability across Europe.
BACKGROUND: Valproate (VPA) is a known teratogen associated with greater risk of major congenital malformations and other neurodevelopmental sequelae than all other licensed antiepileptic medicines. To reduce the potential ...
Epilepsy, anti-seizure medication, intellectual disability and challenging behaviour - Everyone's business, no one's priority.
PURPOSE: People with Intellectual Disability (ID) and epilepsy are more likely to experience psychiatric conditions, challenging behaviour (CB), treatment resistance and adverse effects of anti-seizure medications (ASM) ...